CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016		Mar. 31, 2015
Cash flows from operating activities:
Net income	$ 831		$ 978
Adjustments to reconcile net income to net cash provided by operating activities:
Deferred income tax expense	424		0
Provision for depreciation and amortization	162		176
Net amortization of bond premiums and discounts	216		263
Stock based compensation	77		143
Gain on sale of investment securities	0		(56)
Gain on sale of foreclosed assets, net	(5)		(16)
Valuation adjustment on foreclosed assets	12		116
Earnings on investment in bank-owned life insurance	(43)		(50)
Gain on sale of mortgage loans held for sale	(100)		(111)
Originations of mortgage loans held for sale	(4,141)		(5,879)
Proceeds from sale of loans held for sale	4,656		5,364
Changes in assets and liabilities:
Other assets	(207)		821
Accrued interest receivable	37		80
Other liabilities	(557)		597
Accrued interest payable	2		23
Net cash provided by operating activities	1,364		2,449
Cash flows from investing activities:
Proceeds from sales and calls of investment securities available-for-sale	0		2,609
Proceeds from maturities and calls of investment securities held-to-maturity	100		0
Proceeds from paydowns of investment securities available-for-sale	1,280		1,157
Proceeds from paydowns of investment securities held-to-maturity	2,905		3,409
Purchases of investment securities available-for-sale	0		(2,538)
Redemption of certificates of deposits held for investment	980		99
(Purchase) redemption of FHLB stock	(308)		224
Net increase in loans outstanding	(18,925)		(6,595)
Purchases of bank premises and equipment	(224)		(68)
Proceeds from sales of foreclosed assets	134		1,036
Net cash used in investing activities	(14,058)		(667)
Cash flows from financing activities:
Net proceeds from borrowings	10,000		0
Net increase (decrease) in deposit accounts	19,044		(57,674)
Proceeds from issuance of common stock	26		17
Excess tax benefits from stock options	1		0
Shares withheld for payment of taxes	(71)		0
Net cash provided by (used in) financing activities	29,000		(57,657)
Change in cash and cash equivalents	16,306		(55,875)
Cash and cash equivalents at beginning of period	26,755	[1]	158,527
Cash and cash equivalents at end of period	43,061		102,652
Supplemental disclosures of cash flow information:
Interest paid on deposits and borrowings	1,218		1,691
Supplemental disclosures of noncash investing and financing activities:
Unrealized gains on investment securities available-for-sale	1,549		571
Amortization of net losses on investment securities transferred to held-to-maturity	(11)		(16)
Transfer of loans to foreclosed assets	863		619
Loans transferred from held for sale to held for investment	0		105
Loans transferred from held for investment to held for sale	0		113
Available for sale securities purchased, not yet settled	$ 0		$ 1,805

[1] Derived from audited consolidated financial statements.